Recovery and Survival of EryDex in Non-patient Volunteers

Summary

This is a randomized, single-blind, single-center, concurrently controlled, exploratory, Phase I study to determine the in vivo kinetics (24-hour post-infusion recovery and T50 survival) of EryDex System (EDS) -processed autologous red blood cells (RBC) in non-patient volunteers. A total of 12 non-patient volunteer subjects will be enrolled and assigned to one of the 2 groups (6 subjects in active arm group, 6 subjects in sham arm group).

Timeline

Start

2015-01

Primary completion

2015-06

Completion

2015-06

Drugs

Indications

No indication recorded.